Loading...
•
Jun 30, 2022
NeueHealth Q2 2022 Earnings Report
Reported strong performance due to progress in reducing medical costs, accurate risk adjustment capture, and improving operational performance.
Key Takeaways
Bright Health Group reported a revenue of $1.6 billion, up 41.5% from Q2'21. The GAAP Net Loss was $251.3 million, and the Adjusted EBITDA Loss was $194.9 million. The Enterprise Medical Cost Ratio was 88.8%. The company reaffirmed its 2022 Consolidated Revenue, MCR, and Adjusted EBITDA guidance.
Revenue of $1.6 billion, up 41.5% from Q2'21.
GAAP Net Loss of $251.3 million.
Adjusted EBITDA Loss of $194.9 million.
Enterprise Medical Cost Ratio of 88.8%.
Forward Guidance
Bright Health Group expects a total revenue of $6.8 billion to $7.1 billion with an expected enterprise Medical Cost Ratio between 90% and 94%. Bright HealthCare end-of-year membership is expected to be approximately 1,000,000, while NeueHealth Revenue is expected to be approximately $2.2 billion. Adjusted EBITDA for 2022 is expected to be a loss of between $500.0 million and $800.0 million
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...